Evaluation of the pharmacokinetics and metabolism of a novel histone deacetylase inhibitor, KBH-A40, in rats

By Oh S. J.   Lee K.   Ryu J.   Yu H. E.   Han G.   Park S. K.   Kang J. S.   Kim H. M.   Kim Y. C.  

Xenobiotica, Vol. 41, Iss. 2, 2011-02 ,pp. : 155-163

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics, oral bioavailability and metabolism of a novel isoquinolinone-based melatonin receptor agonist in rats

By Zhu Jing   Hu Yueqing   Ho Maurice K. C   Wong Yung H.  

Xenobiotica, Vol. 42, Iss. 11, 2012-11 ,pp. : 1138-1150

Informa Healthcare

Access to resources Recommend Favorite

Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man

By Allan G.   Davis J.   Dickins M.   Gardner I.   Jenkins T.   Jones H.   Webster R.   Westgate H.  

Xenobiotica, Vol. 38, Iss. 6, 2008-06 ,pp. : 620-640

Informa Healthcare

Access to resources Recommend Favorite

In vitro metabolism and in vivo pharmacokinetics of quinoline 3-carboxamide derivatives in various species

By Tuvesson H   Hallin I   Ellman M   Sparre B   Gunnarsson P. O   Seidegård J  

Xenobiotica, Vol. 35, Iss. 3, 2005-03 ,pp. : 293-304

Informa Healthcare

Access to resources Recommend Favorite

Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase

By Giuliano C.   Fiore F.   Di Marco A.   Padron Velazquez J.   Bishop A.   Bonelli F.   Gonzalez-paz O.   Marcucci I.   Harper S.   Narjes F.   Pacini B.   Monteagudo E.   Migliaccio G.   Rowley M.   Laufer R.  

Xenobiotica, Vol. 35, Iss. 10-11, 2005-10 ,pp. : 1035-1054

Informa Healthcare

Access to resources Recommend Favorite